NO146542B - STABILIZED DRY CULTURES OF Lactic Acid-Producing Bacteria - Google Patents
STABILIZED DRY CULTURES OF Lactic Acid-Producing Bacteria Download PDFInfo
- Publication number
- NO146542B NO146542B NO751586A NO751586A NO146542B NO 146542 B NO146542 B NO 146542B NO 751586 A NO751586 A NO 751586A NO 751586 A NO751586 A NO 751586A NO 146542 B NO146542 B NO 146542B
- Authority
- NO
- Norway
- Prior art keywords
- cells
- solids
- dried
- weight
- drying
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 29
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 26
- 239000001963 growth medium Substances 0.000 claims description 23
- 239000007787 solid Substances 0.000 claims description 21
- 238000001035 drying Methods 0.000 claims description 16
- 239000004310 lactic acid Substances 0.000 claims description 13
- 235000014655 lactic acid Nutrition 0.000 claims description 13
- 239000002609 medium Substances 0.000 claims description 11
- -1 ascorbate compound Chemical class 0.000 claims description 10
- 229960005070 ascorbic acid Drugs 0.000 claims description 10
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 9
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 9
- 235000010323 ascorbic acid Nutrition 0.000 claims description 9
- 239000011668 ascorbic acid Substances 0.000 claims description 9
- 230000001580 bacterial effect Effects 0.000 claims description 9
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 9
- 238000001694 spray drying Methods 0.000 claims description 9
- 239000002211 L-ascorbic acid Substances 0.000 claims description 8
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 8
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 7
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 7
- 229940072107 ascorbate Drugs 0.000 claims description 7
- 238000000855 fermentation Methods 0.000 claims description 7
- 230000004151 fermentation Effects 0.000 claims description 7
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 7
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 claims description 7
- 239000004223 monosodium glutamate Substances 0.000 claims description 7
- 238000011534 incubation Methods 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 3
- 235000003704 aspartic acid Nutrition 0.000 claims description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 3
- 230000002349 favourable effect Effects 0.000 claims description 3
- 235000013922 glutamic acid Nutrition 0.000 claims description 3
- 239000004220 glutamic acid Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims description 2
- 230000006641 stabilisation Effects 0.000 claims description 2
- 238000011105 stabilization Methods 0.000 claims description 2
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 238000000034 method Methods 0.000 description 12
- 235000013618 yogurt Nutrition 0.000 description 12
- 238000004108 freeze drying Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 239000000654 additive Substances 0.000 description 7
- 235000008504 concentrate Nutrition 0.000 description 7
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 235000020183 skimmed milk Nutrition 0.000 description 6
- 238000007710 freezing Methods 0.000 description 5
- 230000008014 freezing Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 235000021262 sour milk Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000001816 cooling Methods 0.000 description 4
- 238000005057 refrigeration Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 3
- 229960000367 inositol Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 240000002605 Lactobacillus helveticus Species 0.000 description 2
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 2
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 235000014962 Streptococcus cremoris Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 229940054346 lactobacillus helveticus Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000011814 protection agent Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 241000186866 Lactobacillus thermophilus Species 0.000 description 1
- 241000194041 Lactococcus lactis subsp. lactis Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000014969 Streptococcus diacetilactis Nutrition 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007798 antifreeze agent Substances 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940068140 lactobacillus bifidus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000029219 regulation of pH Effects 0.000 description 1
- WTWSHHITWMVLBX-DKWTVANSSA-M sodium;(2s)-2-aminobutanedioate;hydron Chemical compound [Na+].[O-]C(=O)[C@@H](N)CC(O)=O WTWSHHITWMVLBX-DKWTVANSSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1232—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt in powdered, granulated or dried solid form
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
Denne oppfinnelse angår stabiliserte, tørrede kulturmediumfaststoffer som utgjør et konsentrat av levedyktige; uskadelige melkesyreproduserende bakterieceller. This invention relates to stabilized, dried culture medium solids which constitute a concentrate of viable; harmless lactic acid-producing bacterial cells.
Kulturer av melkesyrebakterier til kommersiell fremstilling av ost konserveres vanligvis ved frysning, under anvendelse av flytende nitrogen, av kulturen, som dermed nød-vendigvis må oppbevares og distribueres i frossen tilstand. Cultures of lactic acid bacteria for the commercial production of cheese are usually preserved by freezing, using liquid nitrogen, the culture, which must therefore necessarily be stored and distributed in a frozen state.
En slik kr.yogen konservering er rimelig tilfredsstillende når fabrikanten av kulturen og ostefabrikanten har det nødvendige fryse- og kjøleutstyr. Fryste kulturer av visse melkesyrebakterier anvendes også til kommersiell fremstilling av yoghurt og syrnede melkeprodukter.<v> Til hjemmefremstilling av yoghurt og syrnede melkeprodukter er fryste kulturer ikke tilfredsstillende, hvilket skyldes deres relativt høye pris og problemer forbundet med deres håndtering. Such kr.yogen preservation is reasonably satisfactory when the manufacturer of the culture and the cheese manufacturer have the necessary freezing and cooling equipment. Frozen cultures of certain lactic acid bacteria are also used for the commercial production of yoghurt and soured milk products.<v> For home production of yoghurt and soured milk products, frozen cultures are not satisfactory, which is due to their relatively high price and problems associated with their handling.
I Europa og USA har det derfor vært kommersiell praksis å distribuere tørrede kulturer av yoghurt- og surmelkproduserende bakterier til hjemmebruk. Med slike tørrede kulturer har der forekommet alvorlige problemer med hensyn til deres lagerholdbarhet. Selv om detaljistene ofte har sørget for å holde de tørrede kulturer under avkjøling, har produktene uønsket liten lagerholdbarhet. Antallet av levedyktige bakterier forminskes kontinuerlig med tiden under oppbevaring i avkjølt tilstand. In Europe and the USA it has therefore been commercial practice to distribute dried cultures of yoghurt and sour milk producing bacteria for home use. With such dried cultures, serious problems have occurred with regard to their shelf life. Although retailers have often taken care to keep the dried cultures under refrigeration, the products have an undesirably short shelf life. The number of viable bacteria continuously decreases with time during refrigerated storage.
Uten oppbevaring under kjølebetingelser desaktiveres de tørrede kulturer hurtig. For å sikre at der vil være tilstrekkelig med levedyktige celler tilstede til å danne yoghurt og syrnede melkeprodukter etter fabrikantens instruksjoner, har det vært nødvendig å levere et 50 - 200% overskudd av cellene. Dette forøker omkostningene og gjør de med produktene følgende bruks-anvisninger unøyaktige. Without storage under refrigeration conditions, the dried cultures are quickly deactivated. In order to ensure that there will be sufficient viable cells present to form yoghurt and sour milk products according to the manufacturer's instructions, it has been necessary to deliver a 50 - 200% excess of the cells. This increases the costs and makes the instructions for use that follow the products inaccurate.
Lignende problemer gjør seg gjeldende ved fremstilling og distribuering av yoghurt- og surmelkbakterier i form av tabletter for oral inntagelse. De tabletterte,tørre celler kan oppbevares under avkjøling, men selv da skjer det et tap av cellelevedyktigheten med tiden. Når tablettene på emballasjen angis å inneholde en viss minimumsmengde aktive celler pr. tab-lett, må produsenten derfor, for å være på den sikre side, inn-føre et overskudd av celler på det tidspunkt da tablettene fremstilles for å sikre at etiketteringen vil fortsatt være gyldig og nøyaktig mens produktet finnes på lager hos detalj isten. Similar problems arise in the manufacture and distribution of yoghurt and sour milk bacteria in the form of tablets for oral consumption. The tableted, dry cells can be stored under refrigeration, but even then there is a loss of cell viability over time. When the tablets on the packaging are stated to contain a certain minimum amount of active cells per tablet, the manufacturer must therefore, to be on the safe side, introduce a surplus of cells at the time when the tablets are manufactured to ensure that the labeling will remain valid and accurate while the product is in stock at the retailer.
Inntil foreliggende oppfinnelse var det kjent at kommersielt tørrede kulturer av melkesyreproduserende bakterier ikke har tilstrekkelig stabilitet til at de kan oppbevares ved værelsetemperatur. En tilstrekkelig lagerholdbarhet kunne ikke oppnåes med mindre kulturene ble oppbevart ved kjøletemp-eraturer. Med foreliggende fremgangsmåte muliggjøres for første gang distribuering og detalj forhandling av tørrede yoghurt- og surmelkkulturer til hjemmebruk og av tabletterte yoghurt- og surrnelkbakterier uten at det er nødvendig med noen kjøling. Until the present invention, it was known that commercially dried cultures of lactic acid-producing bacteria do not have sufficient stability for them to be stored at room temperature. A sufficient shelf life could not be achieved unless the cultures were stored at refrigerated temperatures. The present method makes it possible for the first time to distribute and retail dried yogurt and sour milk cultures for home use and tableted yogurt and sour garlic bacteria without the need for any refrigeration.
I henhold til oppfinnelsen tilveiebringes der' således stabiliserte, tørrede kulturmediumfaststoffer som utgjør et konsentrat av levedyktige,uskadelige melkesyreproduserende bakterieceller, hvilke faststoffer er fremstilt ved tørring av en fermentert kultur inneholdende disse celler sammen med andre faststoffer som er tilstede ved avslutningen av inkubasjonen av en kultur av cellene i et vandig næringsholdig medium, hvilket medium er tørret til et fuktighetsinnhold på under 5 vekt%, etter at dets pH-verdi er innstilt på en størrelse som er gunstig for cellenes stabilitet etter tørring. De nye stabiliserte, tørrede kulturmediumstoffer er karakteristiske ved at der er tilstede i faststoffene en synergistisk virkende kombinasjon av stabiliseringspotensiatorer omfattende (a) en ascorbatforbindelse valgt blant L-ascorbinsyre og spiselige, vannoppløselige salter av denne syre, og (b) en andre potensiator valgt blant glutaminsyre, asparaginsyre og spiselige,vannoppløselige salter av disse syrer, hvilke potensiatorer er blitt oppløst i den fermenterte kultur for å oppnå effektiv kontakt med cellene før tørring og i mengder svarende til, på molar basis, 4-20 vektdeler L-ascorbinsyre for ascorbatforbindelsens vedkommende, og for den annen potensiator svarende til 1,5 - 20 vektdeler, fortrinnsvis 3-15 vektdeler, mononatriumglutamat pr. 100 vektdeler av den vannfrie samlede vekt av cellene og de andre fer-menterings f ast stoff er . According to the invention, there are thus provided stabilized, dried culture medium solids which constitute a concentrate of viable, harmless lactic acid-producing bacterial cells, which solids are produced by drying a fermented culture containing these cells together with other solids that are present at the end of the incubation of a culture of the cells in an aqueous nutrient medium, which medium has been dried to a moisture content of less than 5% by weight, after its pH value has been adjusted to a value favorable to the stability of the cells after drying. The new stabilized, dried culture medium substances are characteristic in that there is present in the solids a synergistically acting combination of stabilization potentiators comprising (a) an ascorbate compound selected from L-ascorbic acid and edible, water-soluble salts of this acid, and (b) a second potentiator selected from glutamic acid, aspartic acid and edible, water-soluble salts of these acids, which potentiators have been dissolved in the fermented culture to achieve effective contact with the cells before drying and in amounts corresponding, on a molar basis, to 4-20 parts by weight of L-ascorbic acid in the case of the ascorbate compound , and for the second potentiator corresponding to 1.5 - 20 parts by weight, preferably 3-15 parts by weight, of monosodium glutamate per 100 parts by weight of the total anhydrous weight of the cells and the other fermentation solids is .
Uttrykket "melkesyrebakterier" er her brukt for å betegne den store klasse av uskadelige melkesyreproduserende bakterier. Disse bakterier har generelt en evne til å -fermente-re enkle carbohydrater, f.eks. lactose eller fructose, idet melkesyre er i det minste ett av fermenteringsproduktene, og vanligvis det i størst mengde forekommende. Som eksempler på slike melkesyrebakterier kan nevnes følgende: Streptococcus lactis, Streptococcus cremoris, Streptococcus diacetilactis, Streptococcus thermophilus, Lactobacillus bulgaricus, Lactobacillus acidophilus, Lactobacillus helveticus, Lactobacillus bifidus, Lactobacillus casei, Lactobacillus lactis, Lactobacillus plantarum, Lactobacillus delbrueckii, Lactobacillus thermophilus, Lactobacillus fermentii og Pediococcus cerevisiae. The term "lactic acid bacteria" is used here to denote the large class of harmless lactic acid-producing bacteria. These bacteria generally have an ability to ferment simple carbohydrates, e.g. lactose or fructose, lactic acid being at least one of the fermentation products, and usually the one present in the greatest quantity. Examples of such lactic acid bacteria include the following: Streptococcus lactis, Streptococcus cremoris, Streptococcus diacetilactis, Streptococcus thermophilus, Lactobacillus bulgaricus, Lactobacillus acidophilus, Lactobacillus helveticus, Lactobacillus bifidus, Lactobacillus casei, Lactobacillus lactis, Lactobacillus plantarum, Lactobacillus delbrueckii, Lactobacillus thermophilus, Lactobacillus fermentii and Pediococcus cerevisiae.
Foreliggende oppfinnelse er særlig nyttig og frembyr særlige fordeler i forbindelse med fremstillingen av stabiliserte tørrede bakteriekonsentrater av Streptococcus thermophilus, Lactobacillus bulgaricus og Lactobacillus acidophilus, men oppfinnelsen er ikke begrenset til fremstilling av tørrede bakteriekonsentrater av disse tre organismer. Bakteriene Streptococcus termofilus og Lactobacillus bulgaricus betegnes undertiden The present invention is particularly useful and offers particular advantages in connection with the production of stabilized dried bacterial concentrates of Streptococcus thermophilus, Lactobacillus bulgaricus and Lactobacillus acidophilus, but the invention is not limited to the production of dried bacterial concentrates of these three organisms. The bacteria Streptococcus thermophilus and Lactobacillus bulgaricus are sometimes referred to
"yoghurt-bakteriene" og anvendes i alminnelighet til fremstilling av yoghurt. I visse land anvendes Streptococcus thermophilus og Lactobacillus acidofilus til fremstilling av surmelkprodukter. I USA er en "yoqhurt"-kultur oftest en blanding av Streptococcus thermophilus og Lactobacillus bulgaricus. I forbindelse med foreliggende oppfinnelse anvendes the "yoghurt bacteria" and are generally used for the production of yoghurt. In certain countries, Streptococcus thermophilus and Lactobacillus acidophilus are used to produce sour milk products. In the United States, a "yoqhurt" culture is most often a mixture of Streptococcus thermophilus and Lactobacillus bulgaricus. In connection with the present invention is used
imidlertid uttrykket "yoghurt-bakterier" generelt og omfatter én eller flere stammer av Lactobacillus bulgaricus, Streptococcus thermophilus eller Lactobacillus acidofilus, eller en kombinasjon av to eller tre av disse arter. however, the term "yoghurt bacteria" generally and includes one or more strains of Lactobacillus bulgaricus, Streptococcus thermophilus or Lactobacillus acidophilus, or a combination of two or three of these species.
Ved fremstillingen av de stabiliserte, tørrede kulturmediumfaststoffer ifølge foreliggende oppfinnelse dyrkes en ren eller blandet kultur av de ønskede melkesyre-produserende bakterier i et flytende medium som gir tilstrekkelig vekst av In the production of the stabilized, dried culture medium solids according to the present invention, a pure or mixed culture of the desired lactic acid-producing bacteria is grown in a liquid medium which provides sufficient growth of
den eller de angjeldende kulturer. Dette medium kan være sammen-satt av protein eller proteinfraksjoner, forskjellige fermenter-bare carbohydrater, vekststimulanter, uorganiske salter, puffere, etc, eller mediet kan være steril søtmelk, skummetmelk, valle eller andre naturlige substrater, eller de kan være kombinasjo-ner derav. Vekstmediet kan oppvarmes eller steriliseres til potensiering av en tilfredsstillende vekst. Etter den ønskede varmebehandling, avkjøling og poding får kulturen lov til å ut-vikle seg under generelt optimale inkuberingsbetingelser med hensyn til tid og temperatur. Avhengig av den eller de organismer som dyrkes, kan inkubasjonstidene være 4-48 timer, og tem-peraturene kan variere fra 15 til 50° C. Det kan også være ønskelig å regulere pH-verdien og mengden av oppløst oxygen. the relevant culture(s). This medium can be composed of protein or protein fractions, various fermentable carbohydrates, growth stimulants, inorganic salts, buffers, etc., or the medium can be sterile sweet milk, skimmed milk, whey or other natural substrates, or they can be combinations thereof . The growth medium can be heated or sterilized to potentiate satisfactory growth. After the desired heat treatment, cooling and inoculation, the culture is allowed to develop under generally optimal incubation conditions with respect to time and temperature. Depending on the organism(s) being cultivated, the incubation times can be 4-48 hours, and the temperatures can vary from 15 to 50° C. It may also be desirable to regulate the pH value and the amount of dissolved oxygen.
Når der er oppnådd tilfredsstillende vekst, avkjøles kulturen When satisfactory growth has been achieved, the culture is cooled
i sitt vekstmedium til mellom 0° og 15° C. in its growth medium to between 0° and 15° C.
Generelt omfatter den metode som anvendes for å oppnå levedyktige celler av melkesyre-produserende bakterier, ikke i seg selv hittil ukjente trinn, men den utføres i overensstemmel-se med kjente metoder for dyrkning av slike bakterier. Når der er oppnådd en tilfredsstillende bakteriepopulasjon i et egnet vekstmedium, kan vekstvæskens pH-verdi være lavere enn den som er ønskelig til fremstilling av et tørret produkt. Slutt-pH-verdien vil typisk ligge i området 4,4 - 5,4. Før tørring av fermenteringsvæsken er det fordelaktig å tilsette et alkalisk reagens, f.eks. natriumhydroxyd, for å heve pH-verdien til et nivå som er gunstigere for bakterienes stabilitet. I alminnelighet er det, som bekjent, ønskelig å regulere pH-verdien oppad mot nøytralitet (pH-verdi 7) , og der foretas regulering til minst pH-verdi 5,8. Der kan anvendes et hvilket som helst i næringsmidler akseptabelt alkali, f.eks. natriumhydroxyd, kaliumhydroxyd, ammoniumhydroxyd og kalsiumhydroxyd. Det foretrekkes å innstille pH-verdien på ca. 6,0 - 6,5. Som spesifikt eksempel kan nevnes at pH-verdien ved tilsetning av natriumhydroxyd kan heves til ca. 6.2. Når der i vekstmediet skal inkorporeres andre tilsetninger, som vil påvirke vekstmediets pH-verdi, f.eks. de ifølge foreliggende oppfinnelse anvendte stabilitetspotensiatorer, kan pH-reguleringen bekvemt utføres til slutt. In general, the method used to obtain viable cells of lactic acid-producing bacteria does not in itself include previously unknown steps, but it is carried out in accordance with known methods for cultivating such bacteria. When a satisfactory bacterial population has been achieved in a suitable growth medium, the pH value of the growth liquid may be lower than that which is desirable for the production of a dried product. The final pH value will typically be in the range 4.4 - 5.4. Before drying the fermentation liquid, it is advantageous to add an alkaline reagent, e.g. sodium hydroxide, to raise the pH to a level that is more favorable for the stability of the bacteria. In general, as is well known, it is desirable to regulate the pH value upwards towards neutrality (pH value 7), and regulation is carried out to at least a pH value of 5.8. Any alkali acceptable in foodstuffs can be used, e.g. sodium hydroxide, potassium hydroxide, ammonium hydroxide and calcium hydroxide. It is preferable to set the pH value to approx. 6.0 - 6.5. As a specific example, the pH value can be raised to approx. 6.2. When other additives are to be incorporated into the growth medium, which will affect the growth medium's pH value, e.g. the stability enhancers used according to the present invention, the pH regulation can conveniently be carried out at the end.
Før tørring av cellene i vekstmediet tilsettes en,kombinasjon av potensiatorer. En ascorbatforbindelse er en av de vesentlige medvirkende potensiatorer for å oppnå den forøkede stabilitet. Uttrykket "ascorbatforbindelse" skal her betegnes L-ascorbinsyre (vitamin C) og dens vannoppløselige spiselige salter. Slike "spiselige salter" er de salter som er godkjent til anvendelse i menneskeføde og er av næringsmiddelkvalitet. Ascorbatforbindelsen bør inkorporeres i en mengde som på mol-basis svarer til 4-20 vektdeler L-ascorbinsyre pr. 100 deler tørrstoff i vekstmediet, hvilket vil si tørrvekten av bakteriecellene + tørrvekten av de andre faststoffer som finnes i vekstmediet. På samme basis tilsettes den annen potensiator i en mengde som på molar^basis svarer til 1,5 - 20 (eller fortrinnsvis 3-15) deler mononatriumglutamat pr. 100 deler av det nevnte totale tørrstoffinnhold i fermenteringsmediet. Uttrykke-ne "glutamatforbindelse" og "aspartatforbindelse" skal her betegnes henholdsvis (a) glutaminsyre og dens spiselige vannopp-løselige salter, og (b) asparaginsyre og dens spiselige vannopp-løselige salter. Der foretrekkes en glutamatforbindelse som hensiktsmessig kan tilsettes i form av mononatriumglutamat. Before drying the cells in the growth medium, a combination of potentiators is added. An ascorbate compound is one of the essential contributory potentiators to achieve the increased stability. The term "ascorbate compound" shall here denote L-ascorbic acid (vitamin C) and its water-soluble edible salts. Such "edible salts" are the salts that are approved for use in human food and are of food quality. The ascorbate compound should be incorporated in an amount which, on a mole basis, corresponds to 4-20 parts by weight of L-ascorbic acid per 100 parts dry matter in the growth medium, which means the dry weight of the bacterial cells + the dry weight of the other solids found in the growth medium. On the same basis, the second potentiator is added in an amount which, on a molar basis, corresponds to 1.5 - 20 (or preferably 3-15) parts of monosodium glutamate per 100 parts of the aforementioned total dry matter content in the fermentation medium. The terms "glutamate compound" and "aspartate compound" shall be used here to refer respectively to (a) glutamic acid and its edible water-soluble salts, and (b) aspartic acid and its edible water-soluble salts. A glutamate compound is preferred which can conveniently be added in the form of monosodium glutamate.
Når vekstmediet tørres ved frysetørring, er det ønskelig å inkorporere et frysebeskyttelsesmiddel. Egnede kjente frysebeskyttelsesmidler er f.eks. inositol, sorbitol, mannitol, glucose, saccharose, maissirup, dimethylsulfoxyd, stivelsesarter og modifiserte stivelsesarter av alle typer, polyvinylpyrro-lidon, maltose eller andre mono- og disaccharider. Tilsetnings-ir.engden kan ligge i om rådet fra 1,0 til 300 g/l av kulturen, avhengig av det angjeldende middels identitet. When the growth medium is dried by freeze drying, it is desirable to incorporate a freeze protection agent. Suitable known antifreeze agents are e.g. inositol, sorbitol, mannitol, glucose, sucrose, corn syrup, dimethylsulfoxide, starches and modified starches of all types, polyvinylpyrrolidone, maltose or other mono- and disaccharides. The addition amount can be in the range from 1.0 to 300 g/l of the culture, depending on the identity of the medium in question.
Der bør anvendes en mengde som effektivt nedsetter cellebeskadi-gelsen ved frysning til et minimum. Når der anvendes en annen tørremetode, f.eks. varmetørring, anvendes ikke noe frysebeskyttelsesmiddel, og der kan generelt anvendes en hvilken som helst av de forskjellige metoder til tørring av bakterier eller nytti-ge biologiske materialer til et pulver. Som eksempler på disse kan nevnes frysetørring, spraytørring, valse- og/eller vakuum-pannetørring. De foretrukne tørremetoder for utfølelse av oppfinnelsen er frysetørring eller spraytørring. An amount should be used that effectively reduces cell damage by freezing to a minimum. When another drying method is used, e.g. heat drying, no freeze protection agent is used, and generally any of the various methods for drying bacteria or useful biological materials into a powder can be used. Examples of these include freeze drying, spray drying, roller and/or vacuum pan drying. The preferred drying methods for realizing the invention are freeze drying or spray drying.
Sammenligningsforsøk som viser de viktige og uventede Comparison experiments that show the important and the unexpected
, resultater som oppnås ved foreliggende oppfinnelse, fremgår av nedenstående forsøk A, B, C og D og de tilhørende tabeller. , results obtained by the present invention, appear from the following experiments A, B, C and D and the associated tables.
Forsøk A Try A
To 2000 ml prøver av rekonstituert skummetmelk, (12 % tørrstoff) podes med en aktiv melkesubkultur av Lactobacillus acidofilus i en mengde på 1,0 % og inkuberes i 8 timer ved 4 0°C. Derpå avkjøles begge prøvene til 7° C. Begge prøvers pH-verdi er under 5,0 etter inkubering og avkjøling. 60 minutter før frysetørring innstilles den ene 2000 ml prøve på pH 6,55 med 50 %-ig natriumhydroxydoppløsning, og den annen prøve (kontroll-prøven) får fortsatt ha pH 4,77. Derpå frysetørres begge prøver. De erholdte tørrede pulveres lagerholdbarhet ved 21° C fremgår av nedenstående tabell A. Analysen for å bestemme antallet av levedyktige organismer er utført etter en gjengs platetellemeto-de til bestemmelse av levedyktige organismer under anvendelse av en standard-yoghurtagar som platedyrkningsmedium. Platene inkuberes ved 37° C i 72 timer. Two 2000 ml samples of reconstituted skimmed milk, (12% solids) are inoculated with an active milk subculture of Lactobacillus acidophilus in an amount of 1.0% and incubated for 8 hours at 40°C. Both samples are then cooled to 7° C. Both samples' pH value is below 5.0 after incubation and cooling. 60 minutes before freeze-drying, one 2000 ml sample is adjusted to pH 6.55 with 50% sodium hydroxide solution, and the other sample (the control sample) must still have a pH of 4.77. Both samples are then freeze-dried. The shelf life of the dried powders obtained at 21° C is shown in table A below. The analysis to determine the number of viable organisms was carried out according to a group plate counting method for determining viable organisms using a standard yogurt agar as plate culture medium. The plates are incubated at 37° C for 72 hours.
Forsøk B Attempt B
Betingelsene og metodene er de samme som i forsøk A The conditions and methods are the same as in experiment A
med den forskjell at der bare fremstilles én prøve på 2000 ml. Til denne tilsettes 25 g mononatriumglutamat (MSG), og pH-verdien innstilles på 6,55 med 50 %-ig natriumhydroxydoppløsning. Etter en henstandstid på 60 minutter for likevektsinnstilling frysetørres fermenteringsmediet inneholdende Lactobacillus acidofilus-cellene. Lagerholdbarheten bestemmes ved 21° C og der fåes følgende resultater: with the difference that only one sample of 2000 ml is produced. 25 g of monosodium glutamate (MSG) is added to this, and the pH value is adjusted to 6.55 with a 50% sodium hydroxide solution. After a waiting time of 60 minutes for equilibrium setting, the fermentation medium containing the Lactobacillus acidophilus cells is freeze-dried. The shelf life is determined at 21° C and the following results are obtained:
Forsøk C Attempt C
Der anvendes lignende betingelser som beskrevet i forsøk A, men denne gang innstilles begge 200 0 ml prøver på pH 6,00 før frysetørringen. Til den ene 2000 ml prøve tilsettes også 25 g L-ascorbinsyre (som tilblandes før pH-innstillingen). Der anvendes en pH på 6,00 i stedet for 6,55 på grunn av de lavere resulterende fuktighetsinnhold i pulveret. Begge pulvere frysetørres. De erholdte tørrede pulveres lagerholdbar-tiet ved 21° C fremgår av nedenstående tabell C. Similar conditions are used as described in experiment A, but this time both 200 ml samples are adjusted to pH 6.00 before freeze-drying. To the one 2000 ml sample, 25 g of L-ascorbic acid (which is mixed before the pH adjustment) is also added. A pH of 6.00 is used instead of 6.55 because of the lower resulting moisture content in the powder. Both powders are freeze-dried. The shelf life of the dried powders obtained at 21° C is shown in table C below.
Forsøk D Try D
2000 ml Lactobacillus acidofilus-kultur fremstilles som beskrevet under forsøk A med den forskjell at pH-verdien som i forsøk C innstilles på 6,00 med 50 %-ig natriumhydroxyd- 2000 ml of Lactobacillus acidophilus culture is prepared as described under experiment A with the difference that the pH value as in experiment C is set to 6.00 with 50% sodium hydroxide
oppløsning etter tilsetning av 25 g L-ascorbinsyre og 25 g mononatriumglutamat (MSG). Prøven frysetørres. Resultatene av lagerholdbarhetsundersøkelsen fremgår av tabell D. solution after adding 25 g of L-ascorbic acid and 25 g of monosodium glutamate (MSG). The sample is freeze-dried. The results of the storage shelf life survey appear in table D.
De ovenfor stående forsøksresultater kan lettest sam-menlignes på basis av følgende sammenfattende tabell. The above test results can be most easily compared on the basis of the following summary table.
Sammenfattende tabell Summary table
(Forsøk A, B, C og D) (Attempt A, B, C and D)
Utførelsesformer av foreliggende oppfinnelse, som kan tilpasses til kommersiell drift, er anført i nedenstående eksempler 1 - 4. Det vil forståes at de negative kontroller som betegnes "gammel metode", bare er medtatt av sammenligningsgrunner, mens de behandlinger som betegnes med "ifølge oppfinnelsen" er utførelsesformer for foreliggende oppfinnelse. Embodiments of the present invention, which can be adapted to commercial operation, are listed in examples 1 - 4 below. It will be understood that the negative controls labeled "old method" are only included for comparison purposes, while the treatments labeled "according to the invention " are embodiments of the present invention.
Eksempel 1 Example 1
To 2000 ml prøver av rekonstituert skummetmelk (12 % skummetmelkfaststoff) oppvarmes i 12 minutter ved 116° C. Deretter avkjøles de til 40° C og podes med 1,0 % av en egnet kultur av Lactobacillus bulgaricus inneholdende ca. 1 milliard levedyktige celler pr. ml. De to på denne måte podede prøver inkuberes deretter ved 40° C i 8 timer, hvorpå de avkjøles hurtig i isvann til 5° C. Den ene fermenterte kultur på 2000 ml betegnes "ifølge oppfinnelsen" og får følgende behandling: 40 g ascorbinsyre, 25 g mononatriumglutamat (MSG) og 25 g inositol tilsettes under rstadig omrøring, og derpå innstilles pH på 6,10 med 50 %-ig natriumhydroxydoppløsning. Den annen 2000 ml fermenterte kultur, som betegnes "gammel metode", undergår ikke denne behandling. Den sistnevnte kultur er kontroll. De to kulturer frysetørres deretter på konvensjonell måte, og de erholdte pulvere oppbevares ved 21° C, og passende platetellin-ger for bestemmelse av antallet av levedyktige organismer utfø-res på Hansens yoghurt-agar, dels straks og dels etter 1, 2 og 3 måneders forløp. Resultatene fremgår av nedenstående tabell I: Two 2000 ml samples of reconstituted skimmed milk (12% skimmed milk solids) are heated for 12 minutes at 116° C. They are then cooled to 40° C and inoculated with 1.0% of a suitable culture of Lactobacillus bulgaricus containing approx. 1 billion viable cells per ml. The two samples inoculated in this way are then incubated at 40° C for 8 hours, after which they are rapidly cooled in ice water to 5° C. The one fermented culture of 2000 ml is designated "according to the invention" and receives the following treatment: 40 g of ascorbic acid, 25 g of monosodium glutamate (MSG) and 25 g of inositol are added with constant stirring, and then the pH is adjusted to 6.10 with a 50% sodium hydroxide solution. The other 2000 ml fermented culture, which is termed "old method", does not undergo this treatment. The latter culture is control. The two cultures are then freeze-dried in a conventional manner, and the powders obtained are stored at 21° C, and appropriate plate counts for determining the number of viable organisms are carried out on Hansen's yoghurt agar, partly immediately and partly after 1, 2 and 3 the course of months. The results appear in Table I below:
Eksempel 2 Example 2
Der anvendes samme metode som beskrevet i eksempel 1 med den forandring at der som forsøksorganisme anvendes Lactobacillus helveticus. Lagerholdbarhetsforsøkene med de erholdte frysetørrede pulvere gir de i nedenstående tabell II anførte resultater: The same method as described in example 1 is used, with the change that Lactobacillus helveticus is used as the test organism. The shelf life tests with the obtained freeze-dried powders give the results listed in Table II below:
Eksempel 3 Example 3
Den i eksempel 1 beskrevne metode anvendes med følgen-de forskjell: Som dyrkningsmedier anvendes to 10 000 ml prøver av rekonstituert skummetmelk (16 % tørrstoff); forsøksorganis-men er Lactobacillus acidofilus; de to erholdte fermenterte kulturer sprøytetørres på et lite sprøytetørringsapparat med en tilførselshastighet for kulturen på 12 - 15 ml/min, en dysehas-tighet på 3,5 kg/cm^ og en utgangstemperatur på 50 - 60° C. The method described in example 1 is used with the following difference: Two 10,000 ml samples of reconstituted skimmed milk (16% solids) are used as culture media; the test organism is Lactobacillus acidophilus; the two obtained fermented cultures are spray-dried on a small spray-drying apparatus with a supply rate for the culture of 12 - 15 ml/min, a nozzle speed of 3.5 kg/cm^ and an outlet temperature of 50 - 60° C.
De lagerholdbarhetsresultater som oppnås med disse to typer av sprøytetørrede pulvere, fremgår av nedenstående tabell The shelf life results achieved with these two types of spray-dried powders are shown in the table below
III. III.
Eksempel 4 Example 4
Den i eksempel 1 beskrevne fremgangsmåte anvendes med følgende forskjell: Som forsøksorganisme anvendes Streptococcus cremoris. Der inkuberes ved 21° C i 16 timer; der tilsettes pr. 2000 ml fermentert kultur 20 g ascorbinsyre, 12,5 g mononatriumglutamat og 12,5 g inositol; pH-verdien innstilles på 6,25 med 50 %-ig natriumhydroxydoppløsning; der anvendes sta-dig en ubehandlet kultur som kontroll; dyrkningsmediene fremstilles som to 2000 ml prøver av rekonstituert skummetmelk (16 % tørrstoff), og der anvendes en gjengs melkeagar (Ellikers) til platetellingsbestemmelsen av antallet av levedyktige organismer. Resultatene fremgår av nedenstående tabell IV. The method described in example 1 is used with the following difference: Streptococcus cremoris is used as the test organism. Incubate at 21° C for 16 hours; is added per 2000 ml fermented culture 20 g ascorbic acid, 12.5 g monosodium glutamate and 12.5 g inositol; The pH value is set to 6.25 with 50% sodium hydroxide solution; an untreated culture is still used as a control; the culture media are prepared as two 2000 ml samples of reconstituted skimmed milk (16% solids), and a batch of milk agar (Ellikers) is used for the plate count determination of the number of viable organisms. The results appear in table IV below.
Eksempel 5 Example 5
Betingelser og fremgangsmåter er de samme som beskrevet i eksempel 1 med den forskjell at der i stedet for MSG anvendes 23 g natriumaspartat. Resultatene fremgår av nedenstående tabell V. Conditions and methods are the same as described in example 1, with the difference that instead of MSG, 23 g of sodium aspartate is used. The results appear in table V below.
Som det fremgår av de ovenstående eksempler, foretas der før tørringen inkorporering av begge potensiatorer i dyrk-ningsmediet-og innstilling av pH-verdien. Det er bekvemt å foreta pH-innstillingen sist da tilsetningen av potensiatorene vil medføre en liten endring i pH-verdien. Disse tilsetninger bør oppløses i det flytende: medium for å oppnå effektiv kontakt med cellene før tørringen. En kort ventetid etter tilsetningen av potensiatorene og etter pH-innstillingen er ønskelig. Cellene bør få lov til å innstille seg i likevekt med tilsetningene. Den minimale holdetid er ikke blitt bestemt, men i alminnelighet er det ønskelig å holde cellene i kontakt med de oppløste tilsetninger i 30 - 60 minutter eller lengre. Ved kommersiell drift er en holdetid på 1 - 2 timer blitt anvendt. Det er ikke As can be seen from the above examples, before drying both potentiators are incorporated into the culture medium and the pH value is adjusted. It is convenient to make the pH setting last as the addition of the potentiators will cause a small change in the pH value. These additives should be dissolved in the liquid: medium to achieve effective contact with the cells before drying. A short waiting period after the addition of the potentiators and after the pH setting is desirable. The cells should be allowed to settle into equilibrium with the additives. The minimum holding time has not been determined, but in general it is desirable to keep the cells in contact with the dissolved additives for 30 - 60 minutes or longer. In commercial operation, a holding time of 1 - 2 hours has been used. It is not
nødvendig å ha lengre holdetid. Kulturmediet inneholdende tilsetningene holdes fortrinnsvis ved en temperatur mellom 0° og 15° C, og den anvendte temperatur er en ikke-frysetemperatur ved hvilken cellene er beskyttet mot tap av levedyktighet. Når den kommer-sielle behandling av en flytende kultur for å få et tørt produkt forsinkes, f.eks. over natten, kan holdetiden fortsettes under de angitte kjølebetingelser. I nærvær av tilsetningene og ved oppbevaring ved en ikke-frysetemperatur på under 15° C forblir cellene i kulturmediet levedyktige etter flere døgns oppbevaring. Det er imidlertid ikke noen grunn for å forsinke tørringen, og vanligvis underkastes kulturen frysetørring eller sprøytetørring i løpet av få timer (2-6 timer) etter inkorporeringen av tilsetningene . necessary to have a longer holding time. The culture medium containing the additives is preferably kept at a temperature between 0° and 15° C, and the temperature used is a non-freezing temperature at which the cells are protected against loss of viability. When the commercial processing of a liquid culture to obtain a dry product is delayed, e.g. overnight, the holding time can be continued under the specified cooling conditions. In the presence of the additives and when stored at a non-freezing temperature of below 15° C, the cells in the culture medium remain viable after several days of storage. However, there is no reason to delay drying, and usually the culture is subjected to freeze-drying or spray-drying within a few hours (2-6 hours) of the incorporation of the additives.
Uttrykket "tørret" er her brukt for å betegne produkter som inneholder høyst 5 vekt% fuktighet. Slike produkter fremkommer umiddelbart i form av et fint pulver eller granuler. Vanligvis kan det dannede produkts gjennomsnittlige fuktighetsinnhold ved enten frysetørring eller sprøytetørring nedsettes til minst 2,5 - 3,5 vekt%. Der er ikke noe minimumsfuktighets-innhold for det tørrede produkt, men i praksis er det vanskelig å fremstille produkter som inneholder mindre enn ca. 1 - 2 vekt% vann. Fortrinsvis inneholder de stabiliserte tørrede konsentrater av melkesyreproduserende bakterieceller, som fremstilles ifølge oppfinnelsen, mindre enn 3,5 vekt% vann, f.eks. 2,5 - 3 vekt% fuktighet. The term "dried" is used here to denote products that contain no more than 5% moisture by weight. Such products appear immediately in the form of a fine powder or granules. Generally, the average moisture content of the formed product can be reduced to at least 2.5 - 3.5% by weight by either freeze drying or spray drying. There is no minimum moisture content for the dried product, but in practice it is difficult to produce products that contain less than approx. 1 - 2% by weight water. Preferably, the stabilized dried concentrates of lactic acid-producing bacterial cells, which are produced according to the invention, contain less than 3.5% by weight of water, e.g. 2.5 - 3% moisture by weight.
Når det ønskes å fremstille tabletter av de stabiliserte tørrede konsentrater med et høyt antall levedyktige celler, kan det stabiliserte tørrede materiale blandes med en til When it is desired to produce tablets from the stabilized dried concentrates with a high number of viable cells, the stabilized dried material can be mixed with a
tablettering egnet sukkerart, f.eks. lactose eller saccharose, hvilket sukkermateriale fortrinnsvis er tableting suitable sugar, e.g. lactose or sucrose, whichever sugar material is preferred
i granulær form som er avpasset etter dens funksjon som tablett-bindemiddel. For eksempel kan 5-10 vektdeler av de stabiliserte tørrede fermenteringsfaststoffer inneholdende cellekonsen-tratet blandes med 90 - 95 deler tabletteringssukkermateriale, og blandingen kan presses til tabletter på vanlige tablette-ringsmaskiner. in granular form tailored to its function as a tablet binder. For example, 5-10 parts by weight of the stabilized dried fermentation solids containing the cell concentrate can be mixed with 90-95 parts of tableting sugar material, and the mixture can be pressed into tablets on ordinary tableting machines.
Der kan til foreliggende oppfinnelses formål anvendes konvensjonelt frysetørrings- og sprøytetørringsapparatur. I de ovenstående eksempler er frysetørringen utført med en frysetørre-maskin fremstilt av Alloy Products. Inc., Waukesha, Wisconsin, og sprøytetørringen er utført i et Nichols/Niro laboratorie-sprøytetørreutstyr. Conventional freeze-drying and spray-drying equipment can be used there for the purposes of the present invention. In the above examples, the freeze-drying is carried out with a freeze-drying machine manufactured by Alloy Products. Inc., Waukesha, Wisconsin, and the spray drying is carried out in a Nichols/Niro laboratory spray drying equipment.
Claims (4)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US517371A US3897307A (en) | 1974-10-23 | 1974-10-23 | Stabilized dry cultures of lactic acid-producing bacteria |
Publications (3)
Publication Number | Publication Date |
---|---|
NO751586L NO751586L (en) | 1976-04-26 |
NO146542B true NO146542B (en) | 1982-07-12 |
NO146542C NO146542C (en) | 1982-10-20 |
Family
ID=24059541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO751586A NO146542C (en) | 1974-10-23 | 1975-05-05 | STABILIZED DRY CULTURES OF Lactic Acid-Producing Bacteria |
Country Status (13)
Country | Link |
---|---|
US (1) | US3897307A (en) |
AU (1) | AU473243B2 (en) |
BE (1) | BE828181A (en) |
CA (1) | CA1041929A (en) |
CH (1) | CH596302A5 (en) |
DE (1) | DE2520128A1 (en) |
DK (1) | DK141822C (en) |
FR (1) | FR2299404A1 (en) |
GB (1) | GB1469218A (en) |
IT (1) | IT1049418B (en) |
NL (1) | NL7505227A (en) |
NO (1) | NO146542C (en) |
SE (1) | SE422079B (en) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4210672A (en) * | 1976-04-02 | 1980-07-01 | Seikenkai | Preparation of yogurt |
US4066794A (en) * | 1976-06-23 | 1978-01-03 | Sylvia Schur | Instant yogurt preparation |
JPS5356380A (en) * | 1976-10-28 | 1978-05-22 | Ajinomoto Co Inc | Preparation for microorganism |
US4140800A (en) * | 1977-06-13 | 1979-02-20 | Leo Kline | Freeze-dried natural sour dough starter |
US4205132A (en) * | 1978-07-17 | 1980-05-27 | Microlife Technics, Inc. | Lyophilization of bacteria |
US4243687A (en) * | 1979-01-10 | 1981-01-06 | Leo Kline | Freeze-dried natural sour dough starter |
JPS5846293B2 (en) * | 1980-04-08 | 1983-10-15 | 明治製菓株式会社 | Bifidobacterium-containing tablet confectionery and its manufacturing method |
US4500548A (en) * | 1982-03-15 | 1985-02-19 | Stauffer Chemical Company | Fermentation aid for conventional baked goods |
US4518696A (en) * | 1983-01-11 | 1985-05-21 | Chr. Hansen's Laboratory, Inc. | Stabilized liquid bacterial suspension for oral administration to animals |
US4624853A (en) * | 1983-02-07 | 1986-11-25 | S. C. Johnson & Son, Inc. | Instant yogurt food product |
US4879239A (en) * | 1983-11-03 | 1989-11-07 | American Type Culture Collection | Method of culturing freeze-dried microorganisms and resultant preparation |
US4672037A (en) * | 1983-11-03 | 1987-06-09 | American Type Culture Collection | Method of culturing freeze-dried microorganisms |
US4766076A (en) * | 1984-06-19 | 1988-08-23 | The State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Method and buffered bulk starter media for propagation of useful bacteria |
US4690894A (en) * | 1985-09-20 | 1987-09-01 | Advanced Mineral Technologies, Inc. | Treatment of microorganisms with alkaline solution to enhance metal uptake properties |
US4720460A (en) * | 1985-04-04 | 1988-01-19 | Miles Laboratories, Inc. | Process for preserving acid producing bacteria and compositions produced thereby |
FI75865C (en) * | 1987-04-07 | 1988-08-08 | Valio Meijerien | TESTANORDNING OCH FOERFARANDE FOER BESTAEMNING AV ANTIBIOTIKA I MJOELK SAMT I DESSA ANVAENDBAR NY STREPTOCOCCUS THERMOPHILUS-STAM. |
US4837036A (en) * | 1987-05-22 | 1989-06-06 | The Pro-Mark Companies, Inc. | Low fat thin-bodied yogurt product and method |
US4837035A (en) * | 1987-05-22 | 1989-06-06 | The Pro-Mark Companies, Inc. | Low fat custard-type yogurt product and method |
GB8824897D0 (en) * | 1988-10-24 | 1988-11-30 | Ici Plc | Biocatalysts |
GB9002003D0 (en) * | 1990-01-29 | 1990-03-28 | Ici Plc | Stabilized cultures of microorganisms |
CH683223A5 (en) * | 1991-10-25 | 1994-02-15 | Nestle Sa | A process for preparing an acidified milk. |
EP0688864A1 (en) * | 1994-06-21 | 1995-12-27 | Societe Des Produits Nestle S.A. | Frozen yoghurt starter |
US5733774A (en) * | 1995-02-02 | 1998-03-31 | Ecoscience Corporation | Method and composition for producing stable bacteria and bacterial formulations |
ATE298363T1 (en) * | 1996-07-09 | 2005-07-15 | Nestle Sa | SPRAY DRYING METHOD |
DE19819475A1 (en) * | 1998-04-30 | 1999-11-04 | Basf Ag | Dry microorganism cultures and methods for their production |
WO2001044181A1 (en) * | 1999-12-17 | 2001-06-21 | Warner Lambert Research And Development Ireland Limited | A process for producing crystalline atorvastatin calcium |
US20030045428A1 (en) * | 2001-07-05 | 2003-03-06 | Microbes, Inc. | Bacillus laterosporus strain CM-3 for promoting grain crop yields |
FR2829147B1 (en) * | 2001-08-30 | 2003-12-12 | Agronomique Inst Nat Rech | PROCESS FOR THE PREPARATION OF A LYOPHILIZED COMPOSITION CONTAINING LACTIC BACTERIA HAVING IMPROVED BACTERIAL VIABILITY AND ACTIVITY DURING AMBIENT TEMPERATURE STORAGE AND COMPOSITION OBTAINED |
ITMI20022344A1 (en) * | 2002-11-05 | 2004-05-06 | Biofarm Srl | FAST DISSOLUTION FILM PRODUCT IN WATER, FOR THE TREATMENT OF MILK WITH BACTERIA AND / OR ENZYMES. |
ATE513551T1 (en) * | 2003-01-24 | 2011-07-15 | Flora Technology Inc | COMPOSITIONS AND METHODS FOR RESTORING BACTERIAL FLORA |
US20040247580A1 (en) | 2003-06-06 | 2004-12-09 | Myung-Jun Chung | Process for preparing double-coated lactic acid bacteria powder using protein and polysaccharide and product by the same |
WO2005060937A1 (en) * | 2003-12-23 | 2005-07-07 | Chr. Hansen A/S | Compressed tablets comprising viable probiotic microorganisms |
WO2007025097A2 (en) | 2005-08-26 | 2007-03-01 | Danisco A/S | Use |
EP1973406B1 (en) | 2005-12-28 | 2014-03-12 | Advanced Bionutrition Corporation | A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form |
ATE530669T1 (en) * | 2006-05-19 | 2011-11-15 | Danisco | MARKED MICROORGANISMS AND CORRESPONDING MARKING METHODS |
CA2673120C (en) | 2006-12-18 | 2012-08-07 | Advanced Bionutrition Corporation | A dry food product containing live probiotic |
US8444967B2 (en) * | 2010-07-09 | 2013-05-21 | Master Supplements, Inc. | Treatment including prebiotic composition for use with probiotics |
PL2126130T3 (en) * | 2007-03-02 | 2015-10-30 | Dupont Nutrition Biosci Aps | Cultures with improved phage resistance |
FR2924307B1 (en) * | 2007-12-04 | 2010-08-27 | Gervais Danone Sa | USE OF L. CASEI SSP. PARACASEI AS ANTIFUNGAL |
BRPI0921730A2 (en) * | 2008-10-31 | 2015-08-18 | Dsm Ip Assets Bv | Compensation to activate and / or stabilize microorganisms |
JP2012518394A (en) * | 2009-02-23 | 2012-08-16 | セーホーエル.ハンセン アクティーゼルスカブ | Method for producing lactic acid bacteria composition |
US20100247712A1 (en) | 2009-03-26 | 2010-09-30 | Rudolph Marvin J | Food compositions compromising dried probiotics, methods of manufacture and uses thereof |
ES2908047T3 (en) | 2009-03-27 | 2022-04-27 | Intervet Int Bv | Microparticle vaccines for oral or nasal vaccination and boosting of animals including fish |
DK2424972T3 (en) * | 2009-04-30 | 2013-10-14 | Actogenix Nv | Cryoprotectants for freeze-drying of lactic acid bacteria |
NZ597053A (en) | 2009-05-26 | 2014-02-28 | Advanced Bionutrition Corp | Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making |
US9504750B2 (en) * | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
EP2529004B1 (en) | 2010-01-28 | 2017-06-07 | Advanced Bionutrition Corporation | Dry glassy composition comprising a bioactive material |
US8445226B2 (en) * | 2010-02-01 | 2013-05-21 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
US7888062B1 (en) | 2010-02-01 | 2011-02-15 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
RU2573324C2 (en) * | 2010-08-13 | 2016-01-20 | Эдванст Байоньютришн Корпорейшн | Stabilising composition for dry storage of biologic materials (versions) |
NZ607870A (en) | 2010-10-20 | 2015-09-25 | Dupont Nutrition Biosci Aps | Lactococcus crispr-cas sequences |
US20140147427A1 (en) * | 2011-06-08 | 2014-05-29 | Organobalance Gmbh | Spray-Dried Lactobacillus Stems/Cells and the Use of Same Against Helicobacter Pylori |
CN102763726A (en) * | 2012-08-15 | 2012-11-07 | 张玉文 | Probiotics yoghourt powder and preparation method thereof |
WO2017019273A1 (en) | 2015-07-29 | 2017-02-02 | Advanced Bionutrition Corporation | Stable dry probiotic compositions for special dietary uses |
EP3369805B1 (en) | 2015-10-30 | 2020-08-26 | Kabushiki Kaisha Yakult Honsha | Method for producing dried microbial cells |
CN105505835B (en) * | 2016-01-25 | 2019-09-27 | 集美大学 | A kind of method and its application improving streptococcus thermophilus activity and alimentary canal tolerance |
WO2019010282A1 (en) * | 2017-07-07 | 2019-01-10 | Osel, Inc. | High potency stable formulations of vaginal lactobacillus |
EP3849574A1 (en) * | 2018-09-10 | 2021-07-21 | Lactobio A/S | Method for reducing the transfer of pathogenic microorganisms |
WO2024081219A1 (en) | 2022-10-14 | 2024-04-18 | Csp Technologies, Inc. | Container and method for storing and stabilizing moisture sensitive products |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3075887A (en) * | 1960-10-03 | 1963-01-29 | Swift & Co | Drying of bacterial cultures |
US3677897A (en) * | 1970-08-31 | 1972-07-18 | George A Jeffreys | Live lactic acid bacteria cultures and process of producing same |
-
1974
- 1974-10-23 US US517371A patent/US3897307A/en not_active Expired - Lifetime
-
1975
- 1975-04-04 CA CA223,858A patent/CA1041929A/en not_active Expired
- 1975-04-15 AU AU80144/75A patent/AU473243B2/en not_active Expired
- 1975-04-21 BE BE155610A patent/BE828181A/en not_active IP Right Cessation
- 1975-04-28 IT IT22794/75A patent/IT1049418B/en active
- 1975-05-01 GB GB1824375A patent/GB1469218A/en not_active Expired
- 1975-05-02 NL NL7505227A patent/NL7505227A/en not_active Application Discontinuation
- 1975-05-05 NO NO751586A patent/NO146542C/en unknown
- 1975-05-06 FR FR7514218A patent/FR2299404A1/en active Granted
- 1975-05-06 DK DK199975A patent/DK141822C/en not_active IP Right Cessation
- 1975-05-06 DE DE19752520128 patent/DE2520128A1/en not_active Withdrawn
- 1975-05-08 CH CH582875A patent/CH596302A5/xx not_active IP Right Cessation
- 1975-07-02 SE SE7507580A patent/SE422079B/en unknown
Also Published As
Publication number | Publication date |
---|---|
SE422079B (en) | 1982-02-15 |
DK141822B (en) | 1980-06-23 |
FR2299404B1 (en) | 1978-02-03 |
NO146542C (en) | 1982-10-20 |
NO751586L (en) | 1976-04-26 |
AU473243B2 (en) | 1976-06-17 |
DK141822C (en) | 1980-11-10 |
BE828181A (en) | 1975-08-18 |
IT1049418B (en) | 1981-01-20 |
US3897307A (en) | 1975-07-29 |
CH596302A5 (en) | 1978-03-15 |
AU8014475A (en) | 1976-06-17 |
DK199975A (en) | 1976-04-24 |
GB1469218A (en) | 1977-04-06 |
FR2299404A1 (en) | 1976-08-27 |
DE2520128A1 (en) | 1976-04-29 |
SE7507580L (en) | 1976-04-26 |
NL7505227A (en) | 1976-04-27 |
CA1041929A (en) | 1978-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO146542B (en) | STABILIZED DRY CULTURES OF Lactic Acid-Producing Bacteria | |
US9848615B2 (en) | Storage stable frozen lactic acid bacteria culture | |
US8597929B2 (en) | Liquid starter cultures having an improved storage stability and use thereof | |
DK2649175T3 (en) | STARTER CULTURE FORMATIONS | |
RU2344168C2 (en) | Application of compounds reacting in nucleinic acid biosynthesis as cryoprotectors | |
Teixeira et al. | Inducible thermotolerance in Lactobacillus bulgaricus | |
US20110256266A1 (en) | Composition for making a dairy product | |
US4226940A (en) | Non-frozen concentrated bacterial cultures | |
US20080113065A1 (en) | Method For The Preparation Of A Starter Culture | |
EP1141233B1 (en) | Liquid starter cultures having improved storage stability and use thereof | |
Vegarud et al. | Autolysis of group N streptococci. Effects of media composition modifications and temperature | |
Foster | VI. Culture preservation | |
JP2001045968A (en) | Production of low-fat yogurt and low-fat yogurt produced by the method | |
JPH08187072A (en) | Food preserving agent and production thereof | |
Whitehead et al. | A review of starter media for cheese making | |
US20220386639A1 (en) | Bacterial composition for controlling fungal spoilage and uses thereof | |
US9289003B2 (en) | Use of compounds involved in biosynthesis of nucleic acids as cryoprotective agents | |
KR100381912B1 (en) | kimchi Starter with Lactic Acid Bacteria in the Cryoprotective Garlic Paste and The Kimchi Composite | |
RU2178646C2 (en) | Method to manufacture liquid or dry ferment for sour milk products | |
RU2080795C1 (en) | Method for producing dry bacterial sour for production cultured milk products | |
WO2023166156A1 (en) | Method for preparing cultures of lactic acid bacteria, products and culture media therefore | |
Matalon | Preservation studies on internal-pH-control-grown yogurt starters | |
Jakubowska et al. | Evaluation of Lactobacillus casei for preparing frozen concentrated starter cultures | |
UA114255C2 (en) | METHOD OF PREPARATION OF BACTERIAL PREPARATION "LST" FOR AMBASSADOR OF RAW MATERIALS |